Hematemesis on Hepatic Cirrhosis Patients in Area with Limited Facilities

Yudha Klahan, Firas Farisi Alkaff

= http://dx.doi.org/10.20473/bhsj.v1i1.8243
Abstract views = 1279 times | downloads = 2933 times


Esophageal variceal haemorrhage is one of the more dangerous complications of hepatic cirrhosis. Initial treatment can determine patient mortality and morbidity. But not all hospitals have adequate facilities and medicines to handle it. The 53-year-old woman came with a diagnosis of ascites and hematemesis. At the initial examination found hypotension. Laboratory results show anemia, thrombocytopenia, and leukocytosis. The next morning the patient's condition worsened and was transferred to ICU. During the ICU patients receive 10 lpm oxygen support, cefobactam, pantoprazole, PRC transfusion, and dopamine. Patients begin conscious  on the 5th day of treatment. Then the patient started getting diuretics on day 6 and propranolol on day 9. On day 13 the patient's condition improved and the patient was discharged for outpatient treatment. Limitations of the endoscopic tool cause not every hospital in Indonesia can perform emergency endoscopy for therapy. However, with rapid and appropriate pharmacological therapy, patients can be helped not to fall into mortality and prevent recurrent bleeding.


Endoscopy; Hematemesis; Esophageal varices; Hepatic Cirrhosis

Full Text:



Nurdjanah S. Sirosis Hati. In: Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S, editors. Buku Ajar Ilmu Penyakit Dalam. 4 ed. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia; 2006. p. 443-6.

Garcia-Tsao G, Bosch J. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2015;13(12):2109-17.

World Gastroenterology Organisation. World Gastroenterology Organisation Global Guidelines: Esophageal Varices. Milwaukee: World Gastroenterology Organisation; 2014. p. 1-14.

Netiana, Juniati SH. Esophageal varices. Jurnal THT-KL. 2010;3(2):15 pages.

Benedeto-Stojanov D, Nagorni A, Bjelaković G, Milanović J, Stojanov D. Predictive Factors of Bleeding from Esophageal Varisces in Patient with Liver Cirrhosis and Portal Hypertension. Facta Universitatis. 2006;12(3):164-7.

Vidyani A, Vianto D, Widodo B, Kholili U, Maimunah U, Sugihartono T, et al. Faktor Risiko Terkait Perdarahan Varises Esofagus Berulang Pada Penderita Sirosis Hati. Jurnal Penyakit Dalam. 2011;12(3):169-74.

Bendtsen F, Krag A, Moller S. Treatment of acute variceal bleeding. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2008;40(5):328-36.

Kim YD. Management of acute variceal bleeding. Clinical endoscopy. 2014;47(4):308-14.

Karjadi T, Widjaja FF. Prevention of Recurrent Bleeding in Liver Cirrhosis Patient. Journal of the Indonesian Medical Association. 2011(Vol. 61 No. 10 October 2011).

Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet. 2003;361(9361):952-4.


  • There are currently no refbacks.

Copyright (c) 2018 Yudha Klahan, Firas Farisi Alkaff

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.



Creative Commons License

This Journal (E-ISSN:2620-8636) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

View BHSJ Stats